Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Altus Medical: Maker of the CoolGlide aesthetic laser for hair removal and vascular lesions files $60 mil. initial public offering with the Securities and Exchange Commission Jan. 4. The Burlingame, California company values the laser hair removal market at about $1.3 bil., with the laser-installed base expected to triple over the next three years. Advantages over electrolysis include the rapid treatment of larger target areas and the ability to remove the hair structure without damaging the skin, according to the firm. Funds from the offering will be used for general corporate proceeds, with a portion potentially to be used to acquire complementary products, technologies or businesses. Altus reported revenue of $9.5 mil. in 2000...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel